Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ric N Price

Showing results (261-270 of 318) with videos related to

Pageof 32
Sort By:
Malaria Journal|October 30, 2010
A study of the TNF/LTA/LTB locus and susceptibility to severe malaria in highland papuan children and adultsLouise M Randall, Enny Kenangalem, Daniel A Lampah, et al.
The Journal of Infectious Diseases|May 27, 2010
Age-related susceptibility to severe malaria associated with galectin-2 in highland PapuansLouise M Randall, Enny Kenangalem, Daniel A Lampah, et al.
Plos Medicine|October 5, 2018
Correction: Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trialTesfay Abreha, Jimee Hwang, Kamala Thriemer, et al.
Plos Neglected Tropical Diseases|October 12, 2023
Clinical performance validation of the STANDARD G6PD test: A multi-country pooled analysisWondimagegn Adissu, Marcelo Brito, Eduardo Garbin, et al.
Plos Neglected Tropical Diseases|February 17, 2022
Repeatability and reproducibility of a handheld quantitative G6PD diagnosticBenedikt Ley, Ari Winasti Satyagraha, Mohammad Golam Kibria, et al.
BMC Medical Research Methodology|September 4, 2023
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trialKamala Thriemer, Robert James Commons, Megha Rajasekhar, et al.
Lancet (London, England)|November 18, 2023
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trialKamala Thriemer, Tamiru Shibiru Degaga, Michael Christian, et al.
Journal of Medicinal Chemistry|February 5, 2019
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial ActivityLian Xue, Da-Hua Shi, Jitendra R Harjani, et al.
The Lancet. Infectious Diseases|September 25, 2023
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysisMegha Rajasekhar, Julie A Simpson, Benedikt Ley, et al.
Plos Neglected Tropical Diseases|June 23, 2022
Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicityJi-Hoon Park, Min-Hee Kim, Edwin Sutanto, et al.
Pageof 32

Showing results (261-270 of 318) with videos related to

Sort By:
Pageof 32
Malaria Journal|October 30, 2010
A study of the TNF/LTA/LTB locus and susceptibility to severe malaria in highland papuan children and adultsLouise M Randall, Enny Kenangalem, Daniel A Lampah, et al.
The Journal of Infectious Diseases|May 27, 2010
Age-related susceptibility to severe malaria associated with galectin-2 in highland PapuansLouise M Randall, Enny Kenangalem, Daniel A Lampah, et al.
Plos Medicine|October 5, 2018
Correction: Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trialTesfay Abreha, Jimee Hwang, Kamala Thriemer, et al.
Plos Neglected Tropical Diseases|October 12, 2023
Clinical performance validation of the STANDARD G6PD test: A multi-country pooled analysisWondimagegn Adissu, Marcelo Brito, Eduardo Garbin, et al.
Plos Neglected Tropical Diseases|February 17, 2022
Repeatability and reproducibility of a handheld quantitative G6PD diagnosticBenedikt Ley, Ari Winasti Satyagraha, Mohammad Golam Kibria, et al.
BMC Medical Research Methodology|September 4, 2023
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trialKamala Thriemer, Robert James Commons, Megha Rajasekhar, et al.
Lancet (London, England)|November 18, 2023
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trialKamala Thriemer, Tamiru Shibiru Degaga, Michael Christian, et al.
Journal of Medicinal Chemistry|February 5, 2019
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial ActivityLian Xue, Da-Hua Shi, Jitendra R Harjani, et al.
The Lancet. Infectious Diseases|September 25, 2023
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysisMegha Rajasekhar, Julie A Simpson, Benedikt Ley, et al.
Plos Neglected Tropical Diseases|June 23, 2022
Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicityJi-Hoon Park, Min-Hee Kim, Edwin Sutanto, et al.
Pageof 32